Leading a new era in Taiwan’s biotechnology — Taiwan Exosome Company pays a courtesy visit to the Chairman of the Taiwan–Japan Relations Association.

On Wednesday, October 15, 2025, Chairman Hung Chi-Chang of Taiwan Exosome Corporation, accompanied by senior executives, visited Mr. Su Jia-chyuan, President of the Taiwan-Japan Relations Association, together with Mr. Hiroyuki Toyota, President of Toyota Holdings Co., Ltd. of Japan, to conduct in-depth discussions on Taiwan-Japan cooperation in regenerative medicine. With a shared vision of establishing an “international driving core” for regenerative medicine, both sides aim to combine Taiwan’s strengths in biotechnology research and development with Japan’s advanced precision medical technologies to promote the internationalization of the exosome industry, establish a globally influential model of Taiwan-Japan collaboration, and open a new chapter for the biomedical sector.